Experienced test preparation tutor and PhD biologist: Full SAT preparation and Biology AP Biology

Ellen's resume

ELLEN FREED, PhD
30-83 29th Street, Apt. B5 (concealed information)
Astoria, NY 11102 (concealed information)
(concealed information)
SUMMARY
Experienced Science/Math/English Tutor and PhD biological scientist.
o Tutored/taught small classrooms to raise student achievement and SAT scores in
reading, writing, math, biology. Also taught reading and study skills.
Supervised students and associates to perform and evaluate laboratory experiments.
Developed excellent public speaking skills; prepared and delivered 100+
presentations for lab groups, scientific meetings, lay audiences.
Wrote grants and secured funding/approval for 4 research projects.
Prepared to teach high school biology, including laboratory experimentation, microscopy.
Possess extensive knowledge of teaching technologies and philosophies.
CURRENT POSITION
Memorial Sloan-Kettering Cancer Center, New York, NY
Research Scientist, Developmental Biology Program Feb. 2010-present
o Performed research on mammalian development and function of the nuclear pore
complex for publication now in preparation.
o Supervised and mentored 3 students studying embryonic development.
TEACHING EXPERIENCE
CHYTEN EDUCATIONAL SERVICES, Lexington, MA
Tutor, both private and classroom 2008-2010
o Taught biology and advanced-placement biology
o Utilized online educational tools
o SAT and ACT preparation: reading, writing and mathematics
o Reading and Study Skills, Algebra 1
Teaching assistantships:
Neurobiology, The Medical School of the University of California, San Diego
Physiology Laboratory, Biology, University of California, San Diego
o Plan to begin education coursework for certification spring/summer 2017
o Passed Massachusetts State Teacher’s exams: General Skills, Middle School
General Science 2010
ADDITIONAL RESEARCH EXPERIENCE
DANA-FARBER CANCER INSTITUTE, Boston, MA
Research Scientist, Department of Medical Oncology 2004-2008
Led a group specializing in translational biology of GI endocrine tumors and
colorectal cancers.
Developed best practice for isolation of DNA from archived specimens for
genomic analysis.
Supervised 1 associate to complete experiments for publication.
Successfully completed experiments to contribute to several additional research
projects (see publications).
ASTRAZENECA R & D BOSTON, Waltham, MA 2000-2004
Scientist, Cancer Bioscience Department
Served as biology team leader and co-manager for drug discovery team.
Supervised/mentored 2 research associates to develop both biochemical and cellbased
assay for project progression.
Co-managed a multidisciplinary group to evaluate criteria for project progression.
Researched and wrote research proposals for internal review of potential new
drug targets and drug resistance mechanisms.
STANFORD UNIVERSITY, Stanford, CA 1996-2000
School of Medicine, Department of Pathology
Post-doctoral Research Associate, Laboratory of Dr. Peter Jackson
Research Area: Cell division cycle.
ONYX PHARMACEUTICALS, Richmond, CA 1991-1995
Post-doctoral Research Associate, Laboratory of Dr. Frank McCormick
Research Area: Cell signaling by the p21ras pathway.
COMPLETED Continuing Education
Read management literature/attended management training 2003
Cold Spring Harbor Laboratory, Cold Spring Harbor, NY
Completed course in Quantitative Imaging: From Cells to Molecules April 2016
EDUCATION
UNIVERSITY OF CALIFORNIA, San Diego, CA 1983-1990
Ph. D., Neurosciences Advisor: Dr. Tony Hunter
Research Areas: Growth control signaling pathways; Cell adhesion.
UNIVERSITY OF CALIFORNIA, San Diego, CA 1979-1982
Research, Neurobiology, Department of Neurosciences
UNIVERSITY OF PENNSYLVANIA, Philadelphia, PA 1974-1979
Bachelor of Arts in Psychology
Cum Laude, with Distinction in psychology
SELECTED PUBLICATIONS (10 of 16)
1. Freed, E., Gailit, J., van der Geer, P., et al,. 1989. A novel integrin beta subunit is
associated with the vitronectin receptor alpha subunit (alpha v) in a human osteosarcoma
cell line and is a substrate for protein kinase C. EMBO J. 8: 2955-2965.
2. Freed, E., and Hunter, T. 1992. A 41-kDa protein is a potential substrate for the
p210bcr-abl protein-tyrosine kinase in CML cells. Mol. Cell. Bio1. 12: 1312-1323.
3. Freed, E., Symons, M., Macdonald, S.G., McCormick, F. and Ruggieri, R. 1994.
Binding of 14-3-3 proteins to the protein kinase Raf and effects on its activation. Science
265: 1713-1716.
4. Freed, E., Lacey, K.R., Huie, P., Lyapina, S.A., Deshaies, R.J., Stearns, T. and
Jackson, P.K. 1999. Components of an SCF ubiquitin ligase localize to the centrosome
and regulate the centrosome duplication cycle. Genes and Development 13: 2242-2257.
5. Reimann, J. D. R., Freed, E., Hsu, J. Y., Kramer, E. R., Peters, J.-M.,
and Jackson, P. K. 2001. Emi1 is a mitotic regulator that interacts with Cdc20 and
inhibits the anaphase promoting complex. Cell, 105: 645-655.
6. Kulke, M. H., Freed, E., (shared 1st authorship) Chiang, D., Philips, J., Zahrieh, D.,
Glickman, J. N., and Shivdasani, R. A., 2008. High-resolution analysis of genetic
alterations in small bowel carcinoid tumors reveals areas of recurrent amplification or
loss and tumor sub-groups with clustered chromosomal alterations. Genes,
Chromosomes, and Cancer, 47: 591-603.
7. Firestein, R., Bass, A. J., Kim, S. Y., Dunn, I.F., Silver, S. J., Guney, I., Freed, E.,
Ligon, A., Vena, N., Ogino, S., Chleda, M., Tamayo, P., Finn, S., Shrestha, Y., Boehm, J.
S., Jain, S., Bojarski,, E., Barretina, J., Chan, J. A., Baselga, J., Tabernero, J., Root, D. E.,
Fuchs, C., Loda, M., Shivdasani, R. A., Meyerson, M., and Hahn, W. C. 2008. CDK8 is
a colorectal oncogene that regulates ®-catenin. Nature, 455: 547-51.
8. Baba, Y., Nosho, K., Shima, K., Freed, E., et al., 2009. Relationship of CDX2 loss
with molecular features and prognosis in colorectal cancer: Implications for clinical and
pathology practice. Clinical Cancer Research, 15: 4665-73.
9. Verzi, M.P., Hatzis, P., Sulahian, R., Philips , J., Schuijers, J., Shin, H., Freed, E.,
Lynch, J. P., Dang, D. T. Brown M., Clevers H., Liu, X., S., and Shivdasani, R. A. 2010.
TCF4 and CDX2, major transcription factors for intestinal function, converge on the
same cis-regulatory regions. Proc. Natl. Acad. Sci. U.S.A., 107(34): 15157-62.
10. Freed, E., Souquet, B., Berto, A., Doye, V. and Lacy, E. 2017. Deletion of Nup133
results in maintained nuclear pore assembly with defects in the nuclear basket. (In
preparation).